Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 21595099)

1.

Drug Class Review: Second-Generation Antidepressants: Final Update 5 Report [Internet].

Gartlehner G, Hansen RA, Reichenpfader U, Kaminski A, Kien C, Strobelberger M, Van Noord M, Thieda P, Thaler K, Gaynes B.

Portland (OR): Oregon Health & Science University; 2011 Mar.

2.

WITHDRAWN: Drugs versus placebo for dysthymia.

Silva de Lima M, Moncrieff J, Soares BG.

Cochrane Database Syst Rev. 2015 Jun 18;6:CD001130. doi: 10.1002/14651858.CD001130.pub2.

PMID:
26087170
3.

Antidepressants for the treatment of depression in people with cancer.

Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M.

Cochrane Database Syst Rev. 2015 Jun 1;6:CD011006. [Epub ahead of print]

PMID:
26029972
4.

Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.

Ori R, Amos T, Bergman H, Soares-Weiser K, Ipser JC, Stein DJ.

Cochrane Database Syst Rev. 2015 May 10;5:CD007803. doi: 10.1002/14651858.CD007803.pub2.

PMID:
25957940
5.

Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.

Olthuis JV, Watt MC, Bailey K, Hayden JA, Stewart SH.

Cochrane Database Syst Rev. 2015 Mar 5;3:CD011565. doi: 10.1002/14651858.CD011565.

PMID:
25742186
6.

Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Ipser JC, Wilson D, Akindipe TO, Sager C, Stein DJ.

Cochrane Database Syst Rev. 2015 Jan 20;1:CD007505. doi: 10.1002/14651858.CD007505.pub2.

PMID:
25601826
7.

Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.

Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, Hetrick SE.

Cochrane Database Syst Rev. 2014 Nov 30;11:CD008324. doi: 10.1002/14651858.CD008324.pub3. Review.

PMID:
25433518
8.

Psychiatric comorbidities in patients with major depressive disorder.

Thaipisuttikul P, Ittasakul P, Waleeprakhon P, Wisajun P, Jullagate S.

Neuropsychiatr Dis Treat. 2014 Nov 10;10:2097-103. doi: 10.2147/NDT.S72026. eCollection 2014.

9.

Psychological, social and welfare interventions for psychological health and well-being of torture survivors.

Patel N, Kellezi B, Williams AC.

Cochrane Database Syst Rev. 2014 Nov 11;11:CD009317. doi: 10.1002/14651858.CD009317.pub2. Review.

PMID:
25386846
10.

Pharmacological interventions for somatoform disorders in adults.

Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ.

Cochrane Database Syst Rev. 2014 Nov 7;11:CD010628. doi: 10.1002/14651858.CD010628.pub2. Review.

PMID:
25379990
11.

Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults.

van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H.

Cochrane Database Syst Rev. 2014 Nov 1;11:CD011142. doi: 10.1002/14651858.CD011142.pub2. Review.

PMID:
25362239
12.

Azapirones versus placebo for panic disorder in adults.

Imai H, Tajika A, Chen P, Pompoli A, Guaiana G, Castellazzi M, Bighelli I, Girlanda F, Barbui C, Koesters M, Cipriani A, Furukawa TA.

Cochrane Database Syst Rev. 2014 Sep 30;9:CD010828. doi: 10.1002/14651858.CD010828.pub2. Review.

PMID:
25268297
13.

Antidepressant treatment for postnatal depression.

Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K.

Cochrane Database Syst Rev. 2014 Sep 11;9:CD002018. doi: 10.1002/14651858.CD002018.pub2. Review.

PMID:
25211400
14.

Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review.

Barton S, Karner C, Salih F, Baldwin DS, Edwards SJ.

Health Technol Assess. 2014 Aug;18(50):1-59, v-vi. doi: 10.3310/hta18500. Review.

15.

Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.

Nussbaumer B, Morgan LC, Reichenpfader U, Greenblatt A, Hansen RA, Van Noord M, Lux L, Gaynes BN, Gartlehner G.

CNS Drugs. 2014 Aug;28(8):699-712. doi: 10.1007/s40263-014-0169-z. Review.

PMID:
24794101
16.

Paroxetine versus other anti-depressive agents for depression.

Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2014 Apr 3;4:CD006531. doi: 10.1002/14651858.CD006531.pub2. Review.

PMID:
24696195
17.

A meta-analysis of inositol for depression and anxiety disorders.

Mukai T, Kishi T, Matsuda Y, Iwata N.

Hum Psychopharmacol. 2014 Jan;29(1):55-63. doi: 10.1002/hup.2369. Epub 2013 Dec 3. Review.

PMID:
24424706
18.

Fluoxetine versus other types of pharmacotherapy for depression.

Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2013 Jul 17;7:CD004185. Review.

PMID:
24353997
19.

Agomelatine versus other antidepressive agents for major depression.

Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M.

Cochrane Database Syst Rev. 2013 Dec 17;12:CD008851. doi: 10.1002/14651858.CD008851.pub2. Review.

PMID:
24343836
20.

Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.

Reichenpfader U, Gartlehner G, Morgan LC, Greenblatt A, Nussbaumer B, Hansen RA, Van Noord M, Lux L, Gaynes BN.

Drug Saf. 2014 Jan;37(1):19-31. doi: 10.1007/s40264-013-0129-4. Review.

PMID:
24338044
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk